Atorvastatin
Brand names: Lipitor, Atorlip, Storvas
HMG-CoA reductase inhibitor (statin)
Atorvastatin is the world's best-selling medicine by prescription volume. It lowers LDL cholesterol by up to 50–60% and reduces the risk of heart attack, stroke, and cardiovascular death in people at risk.
Drug Class
HMG-CoA reductase inhibitor (statin)
Category
Heart & Blood Pressure
Forms Available
Tablets (10 mg, 20 mg, 40 mg, 80 mg)
How It Works
Atorvastatin blocks HMG-CoA reductase, the rate-limiting enzyme in hepatic cholesterol synthesis. When the liver produces less cholesterol, it upregulates LDL receptors on its surface, clearing more LDL particles from the bloodstream. This dual effect — reduced production and increased clearance — lowers LDL by 35–60% depending on dose.
What It's Used For
- Primary prevention of cardiovascular events in high-risk individuals
- Secondary prevention after heart attack or stroke
- Familial hypercholesterolaemia
- Lowering LDL-C and non-HDL-C in mixed dyslipidaemia
Available Forms
Side Effects
Common Side Effects
- Muscle aches (myalgia) — the most common reason patients stop the drug
- Headache
- Nausea and digestive upset (usually mild)
- Joint pain
Serious Side Effects
- Rhabdomyolysis — severe muscle breakdown releasing myoglobin into the blood; rare but potentially life-threatening
- Hepatotoxicity — significant elevation in liver enzymes (uncommon; routine monitoring no longer universally recommended)
- New-onset type 2 diabetes — modest increased risk, outweighed by cardiovascular benefit in most patients
- Immune-mediated necrotising myopathy (very rare, autoimmune)
Drug Interactions
- Strong CYP3A4 inhibitors (clarithromycin, itraconazole, HIV protease inhibitors) — raise atorvastatin levels; increased myopathy risk
- Gemfibrozil and other fibrates — combined myopathy risk; fenofibrate is safer if needed
- Grapefruit juice — inhibits CYP3A4; avoid large quantities
- Warfarin — mild INR increase; monitor
- Digoxin — atorvastatin raises digoxin levels by ~20%
When to Avoid
- Active liver disease or unexplained persistent raised transaminases
- Pregnancy and breastfeeding — statins are teratogenic
- Concomitant use of strong CYP3A4 inhibitors at certain doses
Patient Tips
- Take at any time of day consistently — atorvastatin's long half-life means timing doesn't matter (unlike shorter-acting statins)
- Do not stop taking it because you feel fine — statins prevent future events, not present symptoms
- Report any unexplained muscle pain, weakness, or dark urine to your doctor promptly
- Avoid large quantities of grapefruit juice
- A healthy diet and exercise amplify statin benefits — statins are not a substitute for lifestyle
Does atorvastatin cause muscle damage?
Muscle aches (statin myalgia) are reported by 5–10% of statin users in clinical practice, though randomised trial data suggests much of this may be a nocebo effect (expectation of harm). True statin-induced myopathy (with raised creatine kinase) is less common.
Rhabdomyolysis — severe muscle breakdown — is rare (about 1 in 10,000 patient-years) and far more likely when atorvastatin is combined with drugs that raise its blood concentration.
If you experience significant muscle pain, have your CK checked before stopping the statin — a decision to switch dose or drug can then be made on evidence.
Atorvastatin and diabetes risk
High-dose statins modestly increase the risk of new-onset type 2 diabetes by about 10–12% in susceptible individuals. This risk is real but small, and in virtually all patients at cardiovascular risk the cardiovascular benefit of statins greatly exceeds the diabetes risk.
If you develop diabetes while on a statin, it does not mean you should stop — statins provide benefit in diabetic patients too.
Medical disclaimer
This page is for educational reference only. Always follow the dosage and instructions given by your prescriber or pharmacist. Do not start, stop, or change medicines without medical advice.
Reviewed 2026-06-01 · Looms Medical Team